X4 Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: X4 Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: X4 Pharmaceuticals Inc
Rating: 1.52375
Author: Trendlyne DVM scores

about

X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine recep...

3.94 0.09 (2.34%)

191.85% Gain from 52W Low

358.4K

XNAS Volume

XNAS 27 Jul, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for X4 Pharma Inc is on 07 Aug 2026 for the purpose of X4 Pharmaceuticals Inc Second Quarter Earnings Results for 2026 See details

Not Eligible

Expensive Valuation

13.5 / 100

Technically Neutral

47.5 / 100

1Yr Price target upside is 194%

5 analysts

X4 Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

X4 Pharma Inc Live Stock Price Today, Share Analysis and Chart

X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine recep...

191.85% Gain from 52W Low

SWOT Analysis

X4 Pharma Inc Live Price Chart

X4 Pharma Inc Live Price Chart